Indaptus Therapeutics Inc... (INDP)
AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
0.89
-0.01 (-1.11%)
At close: Jan 15, 2025, 3:21 PM
Ratios (Annual)
Discover comprehensive ratio statement breakdowns that reveal insights into revenue, expenses, and beyond.
Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 | FY10 | FY09 | FY08 |
PE Ratio | -0.96 | -0.87 | -3.03 | -1.88 | -0.35 | -5.4 | -3.15 | -4.88 | -5.82 | -254.22 | -252.47 | -224 | -135.21 | -151.44 | -135.55 | -64.16 |
PS Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
PB Ratio | 1.22 | 0.49 | 0.65 | -28.23 | 1.46 | 4.39 | 1.55 | 2.87 | 1.17 | 152.76 | 138.38 | 169.47 | 131.94 | 71.37 | 339.63 | -163.75 |
P/FCF Ratio | -1.1 | -0.9 | -2.06 | -2.02 | -0.56 | -4.83 | -3.35 | -5.23 | -4.48 | -299.86 | -263.89 | -246.56 | -133.29 | -171.66 | -148.11 | -86.41 |
P/OCF Ratio | -1.1 | -0.92 | -2.07 | -2.02 | -0.58 | -6.02 | -4.11 | -5.44 | -5.27 | -304.64 | -380 | -257.87 | -190.48 | -190.57 | -173.55 | -91.06 |
OCF/S Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Debt / Equity Ratio | 0.01 | 0.00 | 0.00 | n/a | 0.12 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -1.4 |
Quick Ratio | 5.05 | 7.94 | 8.77 | 0.86 | 1.65 | 5.69 | 9.80 | 10.77 | 25.20 | 4.37 | 6.56 | 5.02 | 4.32 | 10.50 | 1.93 | 0.23 |
Current Ratio | 5.05 | 7.94 | 8.77 | 0.86 | 1.65 | 5.69 | 9.80 | 10.77 | 25.20 | 4.37 | 6.56 | 5.02 | 4.36 | 10.50 | 1.93 | 0.23 |
Asset Turnover | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Interest Coverage | n/a | -25.35 | n/a | n/a | -2.33K | -1.88K | -1.73K | -865.38 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Return on Equity (ROE) | -1.28 | -0.56 | -0.21 | 15.01 | -4.13 | -0.81 | -0.49 | -0.59 | -0.2 | -0.6 | -0.55 | -0.76 | -0.98 | -0.47 | -2.51 | 2.55 |
Return on Assets (ROA) | -1.03 | -0.49 | -0.19 | -2.01 | -2.24 | -0.71 | -0.45 | -0.54 | -0.19 | -0.46 | -0.37 | -0.67 | -0.84 | -0.43 | -1.2 | -2.48 |
Return on Capital (ROIC) | -1.35 | -0.61 | -0.21 | 15.14 | -2.7 | -0.8 | -0.5 | -0.61 | -0.21 | -0.71 | -0.42 | -0.78 | -1 | -0.46 | -1.66 | 3.06 |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Net Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
EBITDA Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |